Dr. Vincent C. Bond is a professor and chair of microbiology, biochemistry and immunology at Morehouse School of Medicine. He has over 25 years of experience studying HIV pathogenesis and has authored over 150 scientific publications and communications on the topic. His research has focused on how exosomes released from HIV-infected cells induce apoptosis in bystander CD4+ T cells, contributing to immune activation and HIV propagation. Based on this work, Dr. Bond formed a start-up company called Orunmila Pharma to develop a therapeutic antagonist targeting related cellular processes in cancer and other diseases.